RE:why these people are telling you to sellRestups, "on track 100%" after Liminal moved the anticipated FDA approval date.
What a doofus. From the Feb 2020 presentation.
Click Here Anticipated Milestones: 2021 & beyond • Anticipated RyplazimTM FDA approval and launch
• Topline data from fezagepras Phase 2 studies in respiratory disease
• Topline data from fezagepras Phase 3 study in ALSM
• Advancement of early-stage R&D programs
Newcamo wrote: They want your shares: from latest presentation, again, on track 100%